Home  |  Contact

Cellosaurus M14K (CVCL_8102)

[Text version]

Cell line name M14K
Synonyms M-14-K; M14
Accession CVCL_8102
Secondary accession CVCL_M199
Resource Identification Initiative To cite this cell line use: M14K (RRID:CVCL_8102)
Comments Doubling time: 55 hours (PubMed=23840376).
Omics: Transcriptome analysis.
Disease Pleural epithelioid mesothelioma (NCIt: C45662)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_U345 ! M14P
CVCL_8103 ! M20 [Human mesothelioma]
Sex of cell Male
Category Cancer cell line

PubMed=2323006; DOI=10.1093/carcin/11.4.673
Pelin-Enlund K., Husgafvel-Pursiainen K., Tammilehto L., Klockars M., Jantunen K., Gerwin B.I., Harris C.C., Tuomi T., Vanhala E., Mattson K., Linnainmaa K.
Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.
Carcinogenesis 11:673-681(1990)

Metcalf R.A., Welsh J.A., Bennett W.P., Seddon M.B., Lehman T.A., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B.I., Harris C.C.
p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Cancer Res. 52:2610-2615(1992)

PubMed=9533946; DOI=10.1165/ajrcmb.18.4.2943
Kahlos K., Anttila S., Asikainen T., Kinnula K., Raivio K.O., Mattson K., Linnainmaa K., Kinnula V.L.
Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma.
Am. J. Respir. Cell Mol. Biol. 18:570-580(1998)

Kahlos K.
The expression and possible role of manganese superoxide dismutase in malignant pleural mesothelioma.
Thesis PhD (1999), University of Oulu, Finland

PubMed=11251971; DOI=10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M
Kettunen E., Nissen A.-M., Ollikainen T., Taavitsainen M., Tapper J., Mattson K., Linnainmaa K., Knuutila S., El-Rifai W.
Gene expression profiling of malignant mesothelioma cell lines: cDNA array study.
Int. J. Cancer 91:492-496(2001)

PubMed=11283936; DOI=10.1002/1097-0142(20010401)91:7<1349::AID-CNCR1138>3.0.CO;2-D
Kahlos K., Soini Y., Sormunen R., Kaarteenaho-Wiik R., Paakko P., Linnainmaa K., Kinnula V.L.
Expression and prognostic significance of catalase in malignant mesothelioma.
Cancer 91:1349-1357(2001)

PubMed=23840376; DOI=10.1371/journal.pone.0065903
Szulkin A., Nilsonne G., Mundt F., Wasik A.M., Souri P., Hjerpe A., Dobra K.
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.
PLoS ONE 8:E65903-E65903(2013)

Ontologies BTO; BTO:0003999
Other Wikidata; Q54903474
Polymorphism and mutation databases Cosmic; 733822
Entry history
Entry creation04-Apr-2012
Last entry updated07-Sep-2018
Version number11